India Molecular Diagnostic Controls Market, By Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender), Country (India) Industry Trends and Forecast to 2028.
Market Analysis and Insights: India Molecular Diagnostic Controls Market
India molecular diagnostic controls market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.70% in the forecast period of 2021 to 2028 and is expected to reach USD 18.19 million by 2028. Increasing technological advancement and rising healthcare expenditure are the major drivers which propelled the demand of the market in the forecast period.
Molecular diagnostics is the branch of laboratory medicine or clinical pathology that utilizes to analyse biological marker in the proteome and genome. It utilizes the molecular biology to analyze the cells expression on the gene as protein for the prediction of nay diseases, select treatments, and monitor the effectiveness of therapies. Molecular diagnostics control is process of checking purity and efficiency of any reagent which provides a wide range of quality assessment service primarily focused on molecular infectious diseases.
The market for molecular quality controls is being driven by a shift in market players' focus toward developing molecular diagnostic tests for infectious disease detection and cancer detection; an increase in end-user adoption of third-party quality controls, a rise in the number of accredited clinical laboratories, and an increase in demand for external quality assessment support. However, the molecular quality controls market is projected to be hampered by an unfavorable reimbursement environment for molecular diagnostic tests, high costs associated with the quality control procedure, and budget restraints of end-users such as hospitals and clinical laboratories.
The molecular diagnostic controls market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
India Molecular Diagnostic Controls Market Scope and Market Size
Molecular diagnostic controls market is segmented on the basis of product, analyte type, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, India molecular diagnostic controls market is segmented into independent controls and instrument-specific controls. In 2021, independent controls segment is expected to dominate the molecular diagnostic controls market because rising quality standards and adoption rate of molecular quality control drives the market growth.
- On the basis of analyte, India molecular diagnostic controls market is segmented into single-analyte controls and multi-analyte controls. In 2021, the single-analyte controls segment is expected to dominate the molecular diagnostic controls market due to the high through output of diagnosis, improved patient quality, cost effective as well as time saving.
- On the basis of application, India molecular diagnostic controls market is segmented into infectious diseases, oncology, genetic testing and other applications. In 2021, the infectious diseases segment is expected to dominate the molecular diagnostic controls market because rising awareness for the infection diseases, rising technological advancement for the diagnosis and moreover, Covid-19 infection also play a major role in driving the market growth.
- On the basis of end user, India molecular diagnostic controls market is segmented into clinical laboratories, hospitals, IVD manufacturers and contract research organizations, academic & research institutes, and other end users. In 2021, the clinical laboratories segment is expected to dominate the molecular diagnostic controls market because clinical laboratories have well experience professional and well equipped laboratories.
- On the basis of distribution channel, India molecular diagnostic controls market is segmented into direct tender and retail sales. In 2021, the retail sales segment is expected to dominate the molecular diagnostic controls market due to their fastest moving nature, the faster consumption helps in getting many benefits and profits.
Molecular Diagnostic Controls Market Country Level Analysis
The molecular diagnostic controls market is analyzed and market size information is provided on the basis of country, product, analyte type, application, end user, and distribution channel.
Infectious diseases segment in India region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 due to its rising prevalence of STDs related diseases such as HIV, HPV and others.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Private Sector Funding and Technological Advancements are boosting the Market Growth of Molecular Diagnostic Controls
Molecular diagnostic controls market also provides you with detailed market analysis for every country growth in molecular diagnostic controls industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the molecular diagnostic controls market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Molecular Diagnostic Controls Market Share Analysis
Molecular diagnostic controls market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to molecular diagnostic controls market.
The major companies operating in the India molecular diagnostic controls market are Thermo Fisher Scientific Inc., ASURAGEN, INC., Merck KGaA, SERACARE LIFE SCIENCES, Bio-Rad Laboratories, Inc., bioMérieux SA, Abbott and Microbiologics among others.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the molecular diagnostic controls market.
For instance,
- In June 2021, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the molecular diagnostic controls market which also provides the benefit for organization to improve their offering for molecular diagnostic controls.
SKU-
